IPO Date: Aug 10 to Aug 12 2026
Listing Date: Aug 17 2026
1. Funding capital expenditure towards the setting up of infrastructure for a research and development facility and Center of Excellence which will be operated by our wholly-owned Subsidiary, Bigtec and connected office space for our Company, Subsidiaries and Associate,
2. Funding capital expenditure towards the purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit, and
3. General corporate purposes
Plot No. L-46, Phase I I- D Verna Industrial Area Verna, Salcete
South Goa
Goa
403722
0832 6724888
investors@molbiodiagnostics.com
www.molbiodiagnostics.com
KFIN Technologies Ltd.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of other applicable laws, if any, Molbio Diagnostics has informed that it enclosed the Press Release on Unaudited Financial Results for the quarter ended June 30, 2026. This intimation is also available on the Company’s website at www.molbiodiagnostics.com in compliance with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Panchmahal Steel has informed that a meeting of the Board of Directors of the Company will be held on Saturday, the 31st day of October, 2026, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half-year period ended 30th September, 2026. The Trading window for dealing in securities of the Company has been closed from October 1, 2026 as communicated earlier vide its letter dated September 22, 2026 and shall remain closed till 2nd November, 2026 in terms of the 'Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and Immediate Relatives of Designated Persons of the company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Molbio Diagnostics Ltd. IPO is ₹626.58 - 658.39 crore.
The Molbio Diagnostics Ltd. IPO opens for subscription on 2026-08-10 and closes on 2026-08-12.
The price range of Molbio Diagnostics Ltd. IPO is ₹768.00 to ₹807.00.
The lot size of Molbio Diagnostics Ltd. IPO is 18 shares.
The registrar of Molbio Diagnostics Ltd. IPO is KFIN Technologies Ltd..
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.